These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28545047)

  • 21. Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives.
    Luyten J; Ogunjimi B; Beutels P
    Vaccine; 2014 Dec; 32(52):7175-8. PubMed ID: 25454883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination.
    Leung J; Harpaz R; Molinari NA; Jumaan A; Zhou F
    Clin Infect Dis; 2011 Feb; 52(3):332-40. PubMed ID: 21217180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.
    Brisson M; Melkonyan G; Drolet M; De Serres G; Thibeault R; De Wals P
    Vaccine; 2010 Apr; 28(19):3385-97. PubMed ID: 20199763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings.
    Viner K; Perella D; Lopez A; Bialek S; Newbern C; Pierre R; Spells N; Watson B
    J Infect Dis; 2012 May; 205(9):1336-41. PubMed ID: 22454467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program.
    Tanuseputro P; Zagorski B; Chan KJ; Kwong JC
    Vaccine; 2011 Nov; 29(47):8580-4. PubMed ID: 21939721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003.
    Yih WK; Brooks DR; Lett SM; Jumaan AO; Zhang Z; Clements KM; Seward JF
    BMC Public Health; 2005 Jun; 5():68. PubMed ID: 15960856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
    Gao Z; Gidding HF; Wood JG; MacIntyre CR
    Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zoster vaccine: current status and future prospects.
    Oxman MN
    Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
    Goldman GS
    Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Projections of zoster incidence in Australia based on demographic and transmission models of varicella-zoster virus infection.
    Costantino V; Gidding HF; Wood JG
    Vaccine; 2017 Dec; 35(48 Pt B):6737-6742. PubMed ID: 29050801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004.
    Pérez-Farinós N; Ordobás M; García-Fernández C; García-Comas L; Cañellas S; Rodero I; Gutiérrez-Rodríguez A; García-Gutiérrez J; Ramírez R
    BMC Infect Dis; 2007 Jun; 7():59. PubMed ID: 17570859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
    Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
    J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster.
    Ogunjimi B; Willem L; Beutels P; Hens N
    Elife; 2015 Jul; 4():. PubMed ID: 26259874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella-Zoster Virus in Perth, Western Australia: Seasonality and Reactivation.
    Korostil IA; Regan DG
    PLoS One; 2016; 11(3):e0151319. PubMed ID: 26963841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VZV T cell-mediated immunity.
    Weinberg A; Levin MJ
    Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The case against universal varicella vaccination.
    Goldman GS
    Int J Toxicol; 2006; 25(5):313-7. PubMed ID: 16940003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.